Brown Advisory Securities’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-12,970
| Closed | -$433K | – | 386 |
|
|
2017
Q2 | $433K | Sell |
12,970
-26,451
| -67% | -$883K | 0.1% | 205 |
|
|
2017
Q1 | $1.26M | Buy |
+39,421
| New | +$1.26M | 0.31% | 84 |
|
|
2016
Q4 | – | Sell |
-12,651
| Closed | -$581K | – | 342 |
|
|
2016
Q3 | $581K | Sell |
12,651
-7
| -0.1% | -$321 | 0.17% | 144 |
|
|
2016
Q2 | $637K | Sell |
12,658
-1,134
| -8% | -$57.1K | 0.2% | 120 |
|
|
2016
Q1 | $738K | Buy |
13,792
+322
| +2% | +$17.2K | 0.24% | 94 |
|
|
2015
Q4 | $883K | Buy |
13,470
+1,255
| +10% | +$82.3K | 0.3% | 85 |
|
|
2015
Q3 | $691K | Buy |
12,215
+4,592
| +60% | +$260K | 0.25% | 95 |
|
|
2015
Q2 | $450K | Sell |
7,623
-67
| -0.9% | -$3.96K | 0.15% | 168 |
|
|
2015
Q1 | $480K | Buy |
+7,690
| New | +$480K | 0.17% | 146 |
|